Skip to main content
John Glick, MD, Oncology, Philadelphia, PA

John H Glick MD

Oncology•Philadelphia, PA

Breast Cancer, Hematologic Oncology

professor of medicine/oncology

Join to view full profile

  • 3400 Civic Center BlvdAbramson Cancer Ctr of the Univ of Penn; PCAM, Ste 3-300SPhiladelphia, PA 19104

  • Phone+1 215-662-6334

  • Fax+1 215-662-4370

Dr. Glick is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Glick's full profileAlready have an account?

Education & Training

  • Stanford Health Care-Sponsored Stanford University
    Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1973 - 1974
  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1971 - 1973
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1969 - 1971
  • Columbia University Vagelos College of Physicians and Surgeons
    Columbia University Vagelos College of Physicians and SurgeonsClass of 1969
  • Princeton University
    Princeton UniversityA.B., Magna Cum Laude, 1965

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1974 - 2026
  • FL State Medical License
    FL State Medical License 2013 - 2018
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma; a study by the Eastern Co-operative Onco...  
    Wiernik PH, Hong F, Glick JH, Bennett JM, Leukemia Lymphoma, 1/1/2009
  • Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer  
    Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B, Senn JH and Panel Members, Annals of Oncology, 1/1/2009
  • Primary Mucosa-associated Tissue Lymphoma of the Breast  
    Rajendran RR, Palazzo, JP, Schwartz GF, Glick JH, Solin L, Clinical Breast Cancer, 1/1/2008

Books/Book Chapters

  • Diseases of the Breast 
    Chapter: Local-Regional Recurrence After Breast Conservation Treatment or Mastectomy 
    Page 1067 - 1087Solin LJ, Harris EER, Orel SG, Glick JHEditors: Harris JR, Lippman ME, Morrow M, Hellman S.2004
  • The American Cancer Society's Clinical Oncology 
    Chapter: Cancer-Related Emergencies 
    Page 733 - 764DeMichele A and Glick JHEditors: Lenhard RE, Osteen RT and Gansler R.American Cancer Society, Atlanta, GA2000
  • Hematology: Basic Principles and Practice 
    Chapter: Hodgkin's Disease: Clinical Manifestations, Staging and Therapy 
    Page 1241 - 1262Portlock CS and Glick JHEditors: Hoffman, et al.Churchill Livingstone, New York, NY2000

Abstracts/Posters

  • Fifteen-Year Results of Breast-Conserving Surgery and Definitive Irradiation for Stage I and II Breast Carcinoma: The University of Pennsylvania Experience
    Santiago RJ, Wu L, Harris E, Fox K, Schultz D, Glick JH, Solin LJ, American Society of Clinical Oncology, 38th Annual Meeting, Orlando, FL, 5/1/2002
  • A Phase I/II dose escalating trial of liposomal doxorubicin (TLCD-99, Myocet) in combination with paclitaxel (Taxol, T) for patients with metastatic breast cancer
    Welles L, Miller WH Jr, Fox K, Batist G, Glick JH, DeMichele A, American Society of Clinical Oncology, Orlando, FL, 1/1/2002
  • Racial differences in hematologic tolerability of adjuvant chemotherapy in breast cancer patients
    DeMichele A, Smith K, Wray L, Klein-Cabral M, Fox K, Schuchter L, Glick JH, American Society of Clinical Oncology, Orlando, FL, 1/1/2002

Lectures

  • Adjuvant Therapy for Early Breast Cancer 
    Multiple Locations, 2001, 2004, 2007, 2011 - 1/1/2011
  • Systemic Therapy for Breast Cancer 
    1/1/2002
  • Breast Cancer: Recent Advances 
    New Brunswick, NJ - 1/1/2002

Press Mentions

  • John Glick to Retire from Penn Medicine
    John Glick to Retire from Penn MedicineJune 4th, 2021
  • An Inspired Life Sparks Generosity, Innovation and Hope
    An Inspired Life Sparks Generosity, Innovation and HopeNovember 21st, 2018
  • Shift in Treating Breast Cancer Is Under Debate
    Shift in Treating Breast Cancer Is Under DebateMay 12th, 2006

Grant Support

  • Senior LeadershipNational Cancer Institute2005–2009
  • Program LeadersNational Cancer Institute2005–2009
  • Planning And EvaluationNational Cancer Institute2005–2009
  • Developmental FundsNational Cancer Institute2005–2009
  • Abramson Cancer Center Of The U Of P Core Support GrantNational Cancer Institute2005–2006

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. John Glick, Dr. John Glick, MD, Dr. J Glick, Dr. John H Glick